Here are four things to know.
1. Through the deal, Allergan will add Zeltiq’s CoolSculpting System to its portfolio of aesthetic products, which includes Botox.
2. The CoolSculpting System is intended to kill fat cells through a cooling mechanism.
3. In 2016, Zeltiq’s fat loss system generated $350 million in sales — paid directly by consumers as insurers do not cover the system, reports Reuters.
4. The deal is expected to close in the second half of 2017.
More articles on supply chain:
Marathon pauses launch of muscular dystrophy drug following price scrutiny: 6 things to know
Glassdoor ranks supply chain manager as 18th best job in US
A look into the supply chains of classic Valentine’s Day gifts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
